# Nuvasive PR, Inc. – FDA Inspection, Feb 11, 2014

Source: https://www.keypedia.com/records/fda_inspections/nuvasive-pr-inc/0222c183-1ca1-43de-9e5d-f0ac07c23fee
Source feed: FDA_Inspections

> FDA inspection 865516 of Nuvasive PR, Inc., February 11, 2014. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 865516
- Company Name: Nuvasive PR, Inc.
- Inspection Date: 2014-02-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1228326 - 2024-01-18
- FDA Inspection 1122594 - 2019-12-09
- FDA Inspection 1014500 - 2017-05-31
- FDA Inspection 969787 - 2016-02-10
- FDA Inspection 887388 - 2014-04-01

Company: https://www.keypedia.com/companies/nuvasive-pr-inc/67fa6b5f-bbe3-4bc0-a510-ee32e5a08c69

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d